Principia Biopharma

54 articles about Principia Biopharma

• 

  Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi

  11/9/2017

  Sanofi will write a check for $40 million upfront.

• Principia Biopharma Presents Late-Breaking Interim Phase II Data Of PRN1008 In Pemphigus At European Academy Of Dermatology And Venereology Meeting

  9/18/2017

• Principia Biopharma Announces PRN1008 Receives Orphan Drug Designation From FDA For Treatment Of Pemphigus Vulgaris

  7/11/2017

• AbbVie And Principia Biopharma Announce Collaboration On Oral Immunoproteasome Inhibitors

  6/13/2017

• ASCO2016: Principia Biopharma Announces Presentation Of Initial Clinical Data On PRN1371 At 2016 American Society Of Clinical Oncology (ASCO) Annual Meeting

  6/6/2016

• Guardant Health Announces Collaboration With Principia Biopharma To Use Guardant360 For Monitoring Patient Response And Tumor Evolution In FGFR Inhibitor Trials

  3/29/2016

• Principia Biopharma Advances BTK Inhibitor Program In Autoimmune Disease And FGFR Inhibitor Program In Oncology

  1/7/2016

• Principia Biopharma Presents Full Phase 1 Clinical Trial Results For PRN1008, A Novel Reversible Covalent BTK Inhibitor, Supporting Further Clinical Development In Autoimmune And Inflammatory Diseases

  6/15/2015

• Principia Biopharma And University of California, San Francisco (UCSF) Scientists Announce Publication Of Seminal Paper On Reversible Covalent Drugs In Nature Chemical Biology

  5/26/2015

• Principia Biopharma Appoints Roy Hardiman As Chief Business Officer And Lewis Shuster To Board Of Directors

  1/12/2015

• Principia Biopharma Successfully Completes Phase 1 Clinical Trial Of PRN1008, A Novel Oral BTK Inhibitor For Autoimmune Diseases

  1/8/2015

• Bay Area's Principia Biopharma Secures $50 Million Series B Financing

  4/22/2014

• Principia Biopharma Expands Executive Management Team

  2/13/2014

• Principia Biopharma Secures $12.5M Second Tranche in Series A Financing, Expands Senior Management Team

  10/29/2012